GlassScriptPhysician profile
Trenton Raff
NPI 1003555178
$371.98
in general payments reported to CMS, 2019-2025
11 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $114 · 2024: $75.71 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $66.73 | 2023-2025 | Fetroja |
| Haemonetics Corporation | $66.34 | 2023-2025 | Teg6s Hemostasis System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.88 | 2025 | Jardiance |
| Csl Behring | $26.42 | 2023 | Kcentra |
| Atricure, INC. | $24.47 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Acera Surgical, INC. | $23.97 | 2025 | Restrata Wound Matrix |
| Alcresta Therapeutics, INC. | $23.72 | 2024 | Relizorb |
| Saranas, INC. | $21.76 | 2023 | |
| Abiomed | $20.94 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $20.80 | 2024 | |
| Melinta Therapeutics, LLC | $17.95 | 2024 | Rezzayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trenton Raff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.